Hiding from allogeneic NK cells and macrophages by a synthetic receptor

Protection of cell therapeutics from antibody-mediated killing by CD64 overexpression

(2023) Alessia Gravina et al.   NATURE BIOTECHNOLOGY

Synthetic immune checkpoint engagers protect HLA-deficient iPSCs and derivatives from innate immune cell cytotoxicity

(2023) Alessia Gravina et al.   Cell Stem Cell

Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application.

(2022) Yuko Kitano et al.   Molecular Therapy-Methods & Clinical Development

Immunogenicity of CAR-T Cell Therapeutics: Evidence, Mechanism and Mitigation

(2022) Aalia N. Khan et al.   Frontiers in Immunology

Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients

(2019) Tobias Deuse et al.   NATURE BIOTECHNOLOGY

Targeted Disruption of HLA Genes via CRISPR-Cas9 Generates iPSCs with Enhanced Immune Compatibility

(2019) Huaigeng Xu et al.   Cell Stem Cell

Generation of hypoimmunogenic human pluripotent stem cells

(2019) Xiao Han et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells

(2017) Germán G Gornalusse et al.   NATURE BIOTECHNOLOGY

Retroviral vector silencing during iPS cell induction: An epigenetic beacon that signals distinct pluripotent states

(2008) Akitsu Hotta et al.   JOURNAL OF CELLULAR BIOCHEMISTRY